Saibene Alberto Maria, Vassena Christian, Pipolo Carlotta, Trimboli Mariele, De Vecchi Elena, Felisati Giovanni, Drago Lorenzo
Department of Otolaryngology-Head and Neck, San Paolo Hospital, University of Milan, Milan, Italy.
Laboratory of Clinical Chemistry and Microbiology, National Institute for Research and Treatment (IRCCS) Galeazzi Orthopaedic Institute, Milan, Italy.
Int Forum Allergy Rhinol. 2016 Jan;6(1):41-5. doi: 10.1002/alr.21629. Epub 2015 Sep 8.
Odontogenic sinusitis and sinonasal complications of dental disease or treatment (SCDDT) play a relevant, often underappreciated role in paranasal sinus infections. Treating SCDDT patients requires tailored medical and surgical approaches in order to achieve acceptable success rates. These approaches differ from common rhinogenic sinusitis treatment protocols mostly because of the different etiopathogenesis. Our study comprehensively evaluated microbiology and antibiotic resistance in SCDDT patients and compared findings with a control group of patients affected by rhinogenic sinusitis.
We performed microbiological sampling during surgery on 28 patients with SCDDT and 16 patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Colonies were isolated, Gram-stained, and the species identified using classic biochemical methods. These results were confirmed by DNA pyrosequencing, and then the resistance profile of each SCDDT isolate to various antibiotics was tested.
Microbial growth was observed in all SCDDT patients, whereas samples from 60% of patients in the control group failed to yield any bacterial growth (p < 0.001). Anaerobes grew in 14% of SCDDT patients as compared to 7% of CRSwNP patients (p = 0.42). Of the isolates from SCDDT patients, 70% were susceptible to amoxicillin/clavulanate, whereas all isolates were susceptible to levofloxacin, teicoplanin, and vancomycin. Of the staphylococci identified, 80% were capable of producing beta-lactamase.
Given the extent of microbiological contamination within the maxillary sinus of SCDDT patients, these infections should be regarded as a different class of conditions from rhinogenic sinusitis. Our findings support the need for different approaches in the treatment of SCDDT patients.
牙源性鼻窦炎以及牙科疾病或治疗引发的鼻窦并发症(SCDDT)在鼻窦感染中发挥着重要作用,但往往未得到充分重视。治疗SCDDT患者需要采用针对性的药物和手术方法,以取得可接受的成功率。这些方法与常见的鼻源性鼻窦炎治疗方案不同,主要是因为发病机制不同。我们的研究全面评估了SCDDT患者的微生物学情况和抗生素耐药性,并将结果与鼻源性鼻窦炎患者的对照组进行了比较。
我们对28例SCDDT患者和16例慢性鼻-鼻窦炎伴鼻息肉(CRSwNP)患者在手术期间进行了微生物采样。分离菌落,进行革兰氏染色,并使用经典生化方法鉴定菌种。这些结果通过DNA焦磷酸测序得到证实,然后测试每个SCDDT分离株对各种抗生素的耐药情况。
所有SCDDT患者均观察到微生物生长,而对照组60%患者的样本未检测到任何细菌生长(p < 0.001)。14%的SCDDT患者培养出厌氧菌,而CRSwNP患者中这一比例为7%(p = 0.42)。在SCDDT患者的分离株中,70%对阿莫西林/克拉维酸敏感,而所有分离株对左氧氟沙星、替考拉宁和万古霉素均敏感。在所鉴定的葡萄球菌中,80%能够产生β-内酰胺酶。
鉴于SCDDT患者上颌窦内微生物污染的程度,这些感染应被视为与鼻源性鼻窦炎不同类型的病症。我们的研究结果支持对SCDDT患者采用不同治疗方法的必要性。